1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
Gastric Cancer Testing, Treatment and Prevention: Technologies and Global Markets

Gastric Cancer Testing, Treatment and Prevention: Technologies and Global Markets

  • October 2015
  • 183 pages
  • ID: 3348546

Summary

Table of Contents

This BCC Research report reviews global markets for biologic therapeutics for gastric cancer and forecasts trends for use of diagnostics, screening and cancer treatment through 2020.

Highlights

-The global gastric cancer diagnostic/screening and treatment market totaled $235.5 billion in 2014. This market is expected to grow from $241.7 billion in 2015 to nearly $318.3 billion by 2020, with a compound annual growth rate (CAGR) of 5.7%.
-The diagnosis/screening segment of the gastric cancer market should total $240.0 billion in 2015 and $315.0 billion by 2020, registering a CAGR of 5.6%.
-The drug therapy segment of this market is expected to increase from $1.5 billion in 2015 to nearly $3.3 billion by 2020, with a CAGR of 14.0%.

INTRODUCTION

STUDY GOALS AND OBJECTIVES

This report, HLC174A – Gastric Cancer Testing, Treatment and Prevention: Technologies and Global Markets, provides a detailed overview and thorough analysis of the present and future global market for gastric cancer diagnostics and therapeutics.

This report analyzes in detail the gastric cancer markets. The report includes products in this market and detailed analyses of markets and competitive environments as well as gastric cancer markets in newly emerging therapeutics and their impact on the market. The report includes information about significant products, key players, issues and trends, current market status of cancer biotherapeutics, strengths, weaknesses, opportunities and threats facing various gastric cancer therapeutics already on the market, major issues involved in the research and development of more effective cancer therapeutics and new cancer therapeutics in development and in clinical trials.

REASONS FOR DOING THE STUDY

The rise in the number of cancer diagnoses and wider access and greater affordability of treatment regimes in developing countries will stimulate growth in the world of gastric cancer therapies market. Stomach cancer is the fifth most common cancer in the world, with 952,000 new cases diagnosed in 2012. The bacterium Helicobacter
pylori is an important cause of distal stomach cancers. Also, Epstein-Barr virus is carcinogenic to humans and has been linked to stomach cancers in some studies.

Consumption of salt and salty foods probably increases the risk of colorectal cancer and consumption of non-starchy vegetables, allium vegetables and fruits probably protect against this cancer.

Newer therapeutics have emerged in the past few years that have had a significant impact on cancer treatment and health. The market for gastric cancer therapies is expected to be about $3.2 billion in 2020. The demand for newer and innovative oncology drugs will continue to grow as healthcare systems worldwide emphasize cancer detection and treatment. This study covers current market status of cancer biotherapeutics, strengths, weaknesses, various cancer biotherapeutics already on the market, major issues involved in the research and development of more effective cancer therapeutics and new cancer therapeutics in development and in clinical trials

SCOPE AND FORMAT

This report will give an overall update on gastric cancer. It will review global markets for biologic therapeutics for gastric cancer and will forecast trends for use of diagnostics, screening and cancer treatment through 2020. It will cover important therapies, biologics, diagnostics, market share, products on the market and market share by company and statistical information for types of cancers prevalent worldwide, with special emphasis on the U.S. market.

Current issues and trends affecting the industry, costs and factors influencing demand will be discussed. The report covers diagnostics, therapeutics, biological products in development, biological products in clinical trials, and currently marketed and late-stage developments in biologic cancer products. In addition, this report includes:

Treatment trends and sales patterns across major cancer indications with market performance of major pharmaceutical companies.

Forecast sales of leading products across major indications to 2020.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Gastrointestinal / GI Stent Market by Type Material Disease, End User - Global Forecast to 2022

Gastrointestinal / GI Stent Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • December 2017
  • by MarketsandMarkets

The gastrointestinal stents market is projected to grow at a CAGR of 5.1% between 2017 and 2022.The gastrointestinal stents market is expected to reach USD 452.6 million by 2022 from USD 353.4 million ...

Cancer/Tumor Profiling Market by Application, Technique ,Technology - Forecast to 2021

Cancer/Tumor Profiling Market: Forecast until 2021

  • $ 5650
  • Industry report
  • January 2018
  • by MarketsandMarkets

The global cancer/tumor profiling market is projected to grow at a CAGR of 10.7%.Global cancer/tumor profiling market is projected to reach USD 8.74 billion in 2022 from USD 5.26 billion in 2017 at CAGR ...

Gene Therapy for Ovarian Cancer- A Pipeline Analysis Report

Gene Therapy for Ovarian Cancer- A Pipeline Analysis Report

  • $ 3500
  • Industry report
  • January 2018
  • by Infiniti Research Limited

About Gene TherapyOvarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cance ...


Download Unlimited Documents from Trusted Public Sources

Cancer and Lymphoma Statistics in Denmark

  • January 2018
    4 pages
  • Cancer  

    Lymphoma  

    Mortality  

  • Denmark  

View report >

Hepatitis Statistics and Cancer Statistics in the UK

  • January 2018
    65 pages
  • Hepatitis  

    Cancer  

    Mortality  

  • United Kingdom  

    Europe  

    United States  

View report >

Ovarian Cancer Statistics in Brazil

  • January 2018
    17 pages
  • Ovarian Cancer  

  • Brazil  

View report >

Related Market Segments :

Cancer

Gastric Cancer

ref:plp2015

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.